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Vaccinia virus capping enzyme is a heterodimer of D1
(844 aa) and D12 (287 aa) polypeptides that executes
all three steps inm7GpppRNA synthesis. The D1 sub-
unit comprises an N-terminal RNA triphosphatase
(TPase)-guanylyltransferase (GTase) module and a
C-terminal guanine-N7-methyltransferase (MTase)
module. The D12 subunit binds and allosterically
stimulates the MTase module. Crystal structures of
the complete D1,D12 heterodimer disclose the
TPase and GTase as members of the triphosphate
tunnelmetalloenzyme and covalent nucleotidyltrans-
ferase superfamilies, respectively, albeit with distinc-
tive active site features. An extensive TPase-GTase
interface clamps the GTase nucleotidyltransferase
and OB-fold domains in a closed conformation
around GTP. Mutagenesis confirms the importance
of the TPase-GTase interface for GTase activity.
The D1,D12 structure complements and rationalizes
four decades of biochemical studies of this enzyme,
which was the first capping enzyme to be purified
and characterized, and provides new insights into
the origins of the capping systems of other large
DNA viruses.
INTRODUCTION
The 50-cap is a distinctive feature of eukaryal cellular and viral
mRNA that is required for mRNA stability and efficient transla-
tion. The cap consists of 7-methylguanosine linked via an
inverted 50-50triphosphate bridge to the initiating nucleoside
of the transcript. The cap is formed by enzymatic modification
of nascent pre-mRNAs synthesized by cellular or viral RNA poly-
merases. Capping entails three enzymatic reactions (Figure 1A).
The 50-triphosphate end of the pre-mRNA is first hydrolyzed to a
diphosphate by RNA 50triphosphatase (TPase). The diphos-
phate RNA is then capped with guanosine monophosphate
(GMP) by RNA guanylyltransferase (GTase) via a two-stepmech-452 Structure 22, 452–465, March 4, 2014 ª2014 Elsevier Ltd All righanism in which (1) GTase reacts with guanosine triphosphate
(GTP) to form a covalent enzyme-(lysyl-Nz)-GMP intermediate
and inorganic pyrophosphate (PPi), (2) GMP is transferred from
GTase to the 50-diphosphate RNA (ppRNA) end to form
GpppRNA. Finally, the GpppRNA cap is converted to a
7-methyl guanosine RNA cap (m7GpppRNA) by AdoMet:
RNA(guanine-N7)-methyltransferase (MTase). This pathway
was elucidated via the analysis of the poxvirus capping enzyme
purified from infectious vaccinia virions (Martin and Moss, 1975,
1976; Martin et al., 1975; Shuman and Hurwitz, 1981; Shuman
et al., 1980; Venkatesan et al., 1980). The same pathway is
conserved in all eukarya, several large DNA viruses, and reovirus
(a double-stranded RNA [dsRNA] virus), though alternative path-
ways are used to cap RNAs in many other RNA viruses (Decroly
et al., 2012).
Whereas the three capping reactions are universal in eukarya
and DNA viruses, there is a remarkable diversity in the genetic
and physical organization of the cap-forming enzymes in
different taxa and in different viruses, ranging from (1) separately
encoded TPase, GTase, andMTase enzymes that have no phys-
ical interactions with each other (e.g., in fission yeast); to (2)
separately encoded enzymes that form complexes in trans
(e.g., budding yeast); to (3) fusions of two of the capping
enzymes within a single polypeptide (e.g., metazoa, plants,
baculovirus); to (4) fusion of all three enzymes in a single poly-
peptide (poxviruses). There is also a complete divergence in
the structure and catalytic mechanism of the TPase enzymes
between taxa. The TPases fall into two classes: (1) the metal-
dependent RNA triphosphatases found in fungi, protozoa, and
large DNA viruses (poxviruses, baculoviruses, Chlorella virus,
and mimivirus) and (2) the metal-independent. cysteine phos-
phatase-type RNA triphosphatases found in metazoans and
plants (Shuman, 2002). In principle, these differences can be
exploited to develop novel anti-infective agents that inhibit path-
ogen capping enzymes, and they also provide instructive clues
to eukaryal phylogeny and evolution of large DNA viruses
(Shuman, 2002).
The vaccinia virus capping enzyme was the first capping
enzyme to be purified and characterized (Martin et al., 1975). It
is a heterodimer of 844 aa and 287 aa polypeptides encoded
by the D1 and D12 genes, respectively, that efficiently executes
all three steps in m7GpppRNA synthesis. Consequently, thets reserved
Figure 1. Overall Structure and Topology
(A) The three reactions catalyzed by the TPase, GTase, and MTase to generate the cap 0 structure.
(B) Schematic diagram showing varying architecture of viral capping enzymes. The TPase is colored in purple, the NTase in green, the OB fold domain in gray, the
MTase in red, and the D12 subunit in yellow.
(C) Overall ribbon representation of the full-length capping enzyme showing separate domains. The domains are colored the same as in (B). The bound AdoHcy
and GTP molecules are shown as sticks.
(D) Schematic topology diagram of the full-length capping enzyme with secondary structure elements labeled. The domains are colored the same as in (B).
Structure
Vaccinia Virus Capping Enzyme Structurevaccinia virus capping enzyme has been used widely as a re-
agent for capping and cap-labeling RNAs in vitro. The physical
organization of vaccinia virus capping enzyme is unique (Fig-Structure 22,ure 1B). D1-(1–545) constitutes an autonomous monomeric
TPase-GTase domain (Myette and Niles, 1996a, 1996b; Yu and
Shuman, 1996). The MTase domain consists of D1-(548–844)452–465, March 4, 2014 ª2014 Elsevier Ltd All rights reserved 453
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Vaccinia Virus Capping Enzyme Structureheterodimerized with the D12 subunit (Cong and Shuman, 1992;
De la Pen˜a et al., 2007; Higman et al., 1992, 1994; Mao and Shu-
man, 1994). The MTase active site is located entirely within D1-
(548–844), which has weak intrinsic methyltransferase activity
that is stimulated allosterically by D12 (Higman et al., 1994;
Mao and Shuman, 1994; Schwer et al., 2006).
The capping apparatus is organized differently in other large
DNA viruses. Mimivirus, a parasite of amoeba, encodes a
1,170-aa trifunctional capping enzyme (MimiCE) that resembles
vaccinia D1, but it does not encode a homolog of vaccinia D12
(Figure 1B). Deletion analysis identified MimiCE-(1–668) as an
autonomous TPase-GTase unit [analogous to vaccinia D1-(1–
545)] and MimiCE-(1–237) as a minimal autonomous TPase
domain (Benarroch et al., 2008). Baculoviruses, which replicate
in arthropod hosts, encode a bifunctional TPase-GTase capping
enzyme analogous to vaccinia D1-(1–545) (Gross and Shuman,
1998) (Figure 1B), but do not encode a cap guanine-N7 methyl-
transferase. The N-terminal 236-aa segment of baculovirus
capping enzyme comprises an autonomous TPase catalytic
domain (Martins and Shuman, 2001). Paramecium bursaria
Chlorella virus 1 encodes separate TPase and GTase enzymes
(Ha˚kansson et al., 1997; Gong and Shuman, 2002) (Figure 1B),
but does not appear to encode a cap guanine-N7 methyltrans-
ferase. Physical separation of the mimivirus, baculovirus, and
Chlorella virus TPase and GTase domains contrasts with the
inability to isolate stand-alone TPase and GTase modules
derived from vaccinia D1-(1–545) (Myette and Niles, 1996b; Yu
et al., 1997).
The domains and three active sites of vaccinia virus capping
enzyme have been charted in detail by mutagenesis with
in vitro and in vivo readouts of TPase, GTase, and MTase activ-
ities (Cong and Shuman, 1995; Gong and Shuman, 2003; Ho
et al., 2000; Mao and Shuman, 1994, 1996; Saha and Shuman,
2001; Saha et al., 2003; Schwer et al., 2006; Yu et al., 1997; Yu
and Shuman, 1996; Zheng and Shuman, 2008a, 2008b). Ana-
lyses of vacciniaMTasewere guided initially by crystal structures
of the homologous eukaryal cellular cap methyltransferase (Fab-
rega et al., 2004) and later by the crystal structure of the vaccinia
D1(MTase),D12 heterodimer (De la Pen˜a et al., 2007). The com-
bined collections of cellular and poxvirus cap MTase structures
with bound substrates and products conferred great power in
interpreting the extensive functional data, yielding important
insights into (1) the basis for cap methyl acceptor specificity,
(2) the mechanism of catalysis of methyl transfer, (3) a unique
methyl donor conformation and S-adenosyl-L-methionine (Ado-
Met)-binding pocket in the poxvirus MTase versus the cellular
homolog (with strong implications for antipoxviral inhibitor
design), (4) protein conformational steps accompanying
substrate binding, and (5) the kinetic mechanism of D12’s
stimulation of D1-MTase activity. Presently, we aspired to attain
a comparably deep understanding of the TPase andGTase com-
ponents of the vaccinia virus capping system.
In this paper, we describe the crystal structure of the full-
length D1,D12 heterodimer with S-adenosyl-L-homocysteine
(AdoHcy) in the methyltransferase active site and with or without
GTP in the GTase active site at 2.8 A˚ and 2.9 A˚ resolution,
respectively. The structures reveal that (1) the poxvirus RNA
triphosphatase domain is a bona fide triphosphate tunnel metal-
loenzyme (TTM) akin to the mimivirus and fungal TPases (Benar-454 Structure 22, 452–465, March 4, 2014 ª2014 Elsevier Ltd All righroch et al., 2008; Lima et al., 1999), and (2) the GTase domain
consists of nucleotidyltransferase (NTase) and oligonucleotide/
oligosaccharide-binding (OB) fold domain modules as in previ-
ously characterized cellular/viral capping enzymes and DNA
ligases (Shuman and Lima, 2004). Closely packed contacts be-
tween the TPase and GTase modules mutually stabilize their
active conformations and account for the prior inability to isolate
autonomous TPase and GTase catalytic domains. Furthermore,
by introducing alanine mutations at the TPase-GTase interface,
we identify lesions that decouple the TPase and GTase. The
TPase-GTase contacts also clamp the NTase and OB fold
domains of the GTase in a closed conformation, restricting inter-
domain flexibility. In addition to structure-guided functional
studies, we discuss insights into the evolution of the capping
apparatus afforded by the structure of vaccinia D1,D12.
RESULTS
Crystallization and Structure Determination of the
Full-Length Vaccinia D1,D12 Heterodimer
The full-length vaccinia D1 and D12 subunits were coexpressed
in bacteria and purified as a 1:1 heterodimer. The D1,D12 pro-
tein, supplemented variously with AdoHcy, AdoMet, m7GpppG,
GTP, and magnesium, crystallized in three different lattices: two
monoclinic (P21 forms 1 and 3) and one triclinic (P1 form 2). The
structure of the D1,D12 complex was solved by molecular
replacement combined with cross-crystal averaging over four
data sets, including native (2.9 A˚ resolution), platinum-derivative
(3.2 A˚), and selenomethionine-derivative (3.5 A˚) crystals in space
group P21 (form 1) and a native crystal (2.9 A˚) in space group P1
(see Materials and Methods and Table 1 for crystallographic sta-
tistics). Models of the triclinic and the monoclinic crystals were
refined independently to R/Rfree values of 25.4/29.8 and 25.2/
29.4, respectively (Table 1). The two refined structures are
extremely similar, except for minor differences in domain orien-
tation. In all determined structures, AdoHcy is found in the
MTase active site. No ligand was observed in the TPase site.
Diffraction data collected for GTP cocrystals in the P1 form
were used to derive the 2.8 A˚ structure of D1,D12 with GTP in
the GTase active site, which was refined to R/Rfree values of
21.0/25.9. The final D1,D12 models included at most 822/844
amino acids of the D1 subunit (lacking residues 28–33 in the
TPase domain, 320–323 and usually 408–411 in the GTase
domain, 531–543 from the linker between the GTase and MTase
domains, and, in the GTP-bound structures, 554–561 in the
MTase domain) and 283/287 amino acids of the D12 subunit
(lacking residues 120–123). The structures have excellent
stereochemistry, with more than 99% of residues in allowed
regions of a Ramachandran plot (Table 1).
The overall structure of the D1,D12 complex is an elongated
U-shape with dimensions of 110 A˚ 3 50 A˚ 3 46 A˚ (Figure 1C).
One lobe of this U-shape consists of the TPase tunnel and the
N-terminal part of the NTase domain of the GTase and has a
length of 56 A˚. The other lobe is formed by the D12 subunit
and is 60 A˚ long. These are connected by the distal half of the
GTase-NTase domain, the OBmodule, and the entire D1 MTase
domain with a width of 110 A˚. The relative arrangement of the
three domains, together with the D12 subunit, opens a deep cleft
with dimensions of 24 A˚ in width and 30 A˚ in depth (Figure 1C).ts reserved
Table 1. Data Collection and Refinement Statistics
Crystal
Form 1 D1,D12 + AdoHcy
SeMet-Labeled
Form 1 D1,D12 +
AdoHcy Pt Soaked
Form 1 D1,D12 +
AdoHcy
Form 2 D1,D12 +
AdoHcy
Form 2 D1,D12 +
AdoHcy + GTP
Data Collection
ESRF Beamline BM14 ID23-EH1 BM14 ID14-EH3 ID14-EH4
Wavelength 0.979 0.921 0.979 0.931 0.976
Space group P21 P21 P21 P1 P1
Cell dimensions
a, b, c (A˚) 61.5, 198.9, 128.3 61.7, 198.2, 116.4 61.7, 200.3, 128.1 61.1, 198.5, 62.0 60.3, 197.7, 61.1
a, b, g () 90.0, 102.2, 90.0 90.0, 101.2, 90.0 90.0, 102.2, 90.0 90.01, 108.31, 94.47 90.13, 109.27, 94.05
Resolution (A˚)a 30.0–3.5 (3.8–3.5) 30–3.2 (3.5–3.2) 30–2.9 (3.0–2.9) 30–2.9 (3.0 2.9) 50–2.8 (2.9–2.8)
Rsym
a 0.204 (0.344) 0.138 (0.301) 0.143 (0.398) 0.125 (0.447) 0.078 (0.646)
I/sIa 5.71 (3.52) 4.57 (2.59) 5.05 (2.13) 5.42 (1.73) 10.75 (1.43)
Completenessa 98.4 (97.2) 98.8 (97.1) 92.0 (81.1) 94.8 (95.4) 96.1 (90.3)
Redundancya 3.79 (3.51) 1.93 (1.89) 1.88 (1.83) 1.90 (1.83) 2.37 (2.31)
Refinement not applicable not applicable
Resolutiona 29.2–2.90 (2.97–2.90) 41.8–2.90 (2.95–2.90) 48.4–2.80 (2.88–2.80)
No. refls work (free) 59,651 (3,174) 55,057 (2,929) 59,782 (3,184)
Rwork
a 25.5 (36.6) 25.2 (36.1) 20.9 (36.4)
Rfree
a 29.7 (37.8) 29.4 (37.8) 25.5 (42.7)
Total non-H atomsb 18,065 17,813 17,863
Ligand (AdoHcy, GTP) 2 3 26 2 3 26 2 3 26, 1 3 32
Solvent molecules 82 76 25
Average B factor 42.4 55.8 76.7
Rmsd
Bond lengths (A˚) 0.005 0.004 0.007
Bond angles () 1.010 0.853 1.126
Ramachandran plotc
Allowed 99.5 99.3 99.1
Favored 93.7 91.3 94.5
refls, reflections.
aHighest-resolution shell is shown in parentheses.
bTwo complexes per asymmetric unit.
cFrom MolProbity: http://molprobity.biochem.duke.edu/.
Structure
Vaccinia Virus Capping Enzyme StructureThe folding topology of the vaccinia virus capping enzyme is
depicted in Figure 1D.
The TPase Domain
The structure of the vaccinia TPase domain (residues 1–225)
clearly indicates that it belongs to the TTM family of RNA triphos-
phatases, as shown by its structural homology to mimivirus
TPase (Z = 12.8 from the Dali server; http://ekhidna.biocenter.
helsinki.fi/dali_server/start) (Holm and Sander, 1993; Benarroch
et al., 2008) and yeast Cet1 (Z = 9.8) (Lima et al., 1999) (Figure 2
and Figure S1 available online). Similarly to these other TPases,
the central core of the vaccinia TPase consists of an antiparallel,
eight-stranded bbarrel (b1 to b8; Figure 1D) that forms a topolog-
ically closed hydrophilic tunnel (Figures 2B–2D). The vaccinia
virus, mimivirus, and yeast Cet1 TPases differ mainly in the posi-
tion of the peripheral a helices that pack against the outer walls of
the tunnel (Figure S1). Cet1 has four helices (aA–aD, shown in
Figure S1A) exclusively located below the bottom floor of the
tunnel, three of which are conserved in the mimivirus and
vaccinia virus TPases (as aA, aB, and aE, shown in FiguresStructure 22,S1B and S1C). Vaccinia TPase has two additional helices
located on the roof of the tunnel (aC and aD, shown in Fig-
ure S1C, connecting strands b3 to b4 and b7 to b8, respectively).
In contrast to the viral TPases, yeast Cet1 is an obligate homo-
dimer (Hausmann et al., 2003; Lima et al., 1999), which explains
the more complex structure of the Cet1 peripheral helices. An
alignment of the viral and yeast TPase structures is shown in
Figure S1D.
The TPase Active Site
The TPase tunnel accommodates the 50-triphosphate end of the
substrate RNA together with at least one divalent metal ion,
which promotes hydrolysis of the g-phosphate (Lima et al.,
1999). The tunnel is lined with charged residues that are parti-
tioned such that one half of the internal surface (the ‘‘roof’’) is
populated almost exclusively by basic residues (Lys65, Lys75,
Arg77, Lys79, Lys107, Lys161, Lys163, exceptionally Glu144)
and the other half (the ‘‘floor’’) by acidic residues (Glu37,
Glu39, Glu126, Asp159, Glu192, Glu194, exceptionally Arg122)
(Figure 2B). These residues include two conserved signature452–465, March 4, 2014 ª2014 Elsevier Ltd All rights reserved 455
Figure 2. The Triphosphatase Domain
(A) Two orthogonal views of the vaccinia TPase in
ribbon representation with secondary structural
elements labeled the same as in Figure 1D and the
structure-based alignment shown in Figure S1D.
(B–D) Comparison of TPase tunnel interiors of the
vaccinia virus (B), Mimivirus (C) (Protein Data Bank
[PDB] ID 2QZE) and yeast Cet1 (D) (PDB ID 1D8I)
enzymes. The structural similarity of vaccinia
TPase as given by DALI to that of Mimivirus is a
root-mean-square deviation (rmsd) of 3.8 A˚ over
183 aligned Ca positions, 12% sequence identity,
and Z score 12.8; and to that of Cet1 is a rmsd of
3.5 A˚ for 163 aligned Ca positions, 15% sequence
identity, and Z score 9.8. Waters are depicted as
red spheres. The manganese ion in the active site
of Cet1 is shown as a purple sphere. The bound
acetate (Mimivirus) and sulfate (Cet1) ions are
shown as sticks. Selected amino acid side chains
in the vaccinia virus, mimivirus, and Cet1 tunnels
are depicted as stick models with blue, gray, and
red carbons, respectively. Residues of TPase
motifs A, B, and C are colored in black, green, and
brown, respectively, in (B), (C), and (D) (see also
Figure S2).
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Vaccinia Virus Capping Enzyme Structuremotifs of tunnel-forming TPases (motifs A and C, shown in Fig-
ure S1D), each containing two metal-coordinating glutamates
(Glu37 and Glu39 in b1 and Glu192 and Glu194 in b8 for vaccinia
virus TPase) that correspond to Glu307, Glu309, Glu494, and
Glu496 in Cet1 and to Glu37, Glu39, Glu212, and Glu214 in mim-
ivirus TPase, respectively (Figures 2B–2D). Previous mutational
analysis of the vaccinia TPase showed that six acidic and three
basic residues are critical for enzymatic activity: Glu37, Glu39,
Arg77, Lys107, Glu126, Asp159, Lys161, Glu192, and Glu194
(Gong and Shuman, 2003; Yu et al., 1997; Yu and Shuman,
1996).
Cet1 and mimivirus TPases contain a third motif (motif B),
which comprises three basic side chains (Arg454, Lys456, and
Arg458 in Cet1) projecting from strand b6 on the side wall of
the tunnel. Based on the structure of Cet1 with bound sulfate456 Structure 22, 452–465, March 4, 2014 ª2014 Elsevier Ltd All rights reservedanion, these basic residues are predicted
to coordinate the negatively charged
RNA 50-triphosphate (Arg454 to the
b-phosphate and Arg458 to the g-phos-
phate), either by direct hydrogen bonding
or by water-mediated hydrogen bonds
(Lima et al., 1999). Motif B is critical for
the TPase activity of fungal and Chlorella
virus TPase (Bisaillon and Shuman, 2001;
Gong and Shuman, 2002; Pei et al., 1999,
2000). Vaccinia TPase lacks a basic motif
B, with the equivalent positions being
substituted by Glu144, Val146, and
Leu148 (Figure S1D). Instead, two basic
side chains on strand b7, Lys161 and
Lys163, are positioned to functionally
replace Cet1 Arg458 and Arg454, respec-
tively. Indeed, Lys161 is essential for
vaccinia TPase function; its mutation toalanine or glutamine elicits a 50-fold decrement in TPase activity
with no impact on GTase activity (Gong and Shuman, 2003).
However, Lys163 has been shown to be dispensable for vaccinia
TPase activity (Gong and Shuman, 2003).
Vaccinia TPase Arg77 (b3) and Lys107 (b4) are the counter-
parts of Arg393 and Lys409 in Cet1 and are essential for activity
(Gong and Shuman, 2003; Yu et al., 1997), probably by coordi-
nating the g phosphate. The active site of the vaccinia TPase is
completed by two acidic side chains: Glu126 (b5) and Asp159
(b7). Glu126 (Glu433 in Cet1) is proposed to serve as a general
base catalyst that coordinates and abstracts a proton from the
water nucleophile that attacks the g phosphorus. Consistent
with this hypothesis, mutating Glu126 effaces vaccinia TPase
activity (Gong and Shuman, 2003). An acidic functional group
is apparently important at position 159 insofar as D159E retains
Structure
Vaccinia Virus Capping Enzyme Structurefull TPase activity, whereas D159A and D159N are 11% and 2%
as active, respectively, as wild-type TPase (Gong and Shuman,
2003). The equivalent aspartate in Cet1 (Asp471) forms a salt
bridge with Cet1 Arg469, which in turn is thought to make a
hydrogen bond with one of the waters in the octahedral
manganese coordination complex. In vaccinia TPase, the argi-
nine position is occupied by Thr157 (b7) which is unlikely to fulfill
the same role.
Lys75 and Lys79 (in strand b3) are constituents of the triphos-
phate tunnel of vaccinia TPase that are conserved in the capping
enzymes of other Poxviridae (Figure S1D), but not as basic resi-
dues in Cet1 or mimivirus TPase. To test whether Lys75 and
Lys79 are relevant for vaccinia TPase activity, we changed
them to alanine in the context of D1-(1–545) and assayed the re-
combinant proteins (Figure S1E) for TPase activity in parallel with
wild-type D1-(1–545). The K75A and K79A mutations had no
deleterious effect on TPase function (Figure S1E). We also
mutated 12 other charged or hydrophilic residues that either
project into the TPase tunnel from the b strands (Arg65,
Glu122, Ser124, Glu144, Gln150, Lys152, Thr157, Ser190, and
Thr196) or out to solvent from the tunnel rim (Arg128 and
Lys152 at one end of the tunnel and Arg142 and Glu112 at the
other end). Most of the positions chosen for this alanine scan
are conserved among poxvirus TPases, except Arg65, Thr157,
and Thr196, but not in Cet1 or mimivirus TPase (Figure S1D).
Our criterion for judging an amino acid important for capping
enzyme function is that its replacement by alanine must cause
at least a fourfold decrement in activity. By this test, none of
the mutated residues are important for nucleotide triphosphate
phosphohydrolase (NTP) activity.
Guanylyltransferase Structure
Capping enzyme GTases, with the exception of those of some
dsRNA viruses, share a common fold with ATP-dependent
DNA ligases (Shuman and Lima, 2004) consisting of two
domains: an N-terminal NTase and a C-terminal OB fold domain.
Structural homology searches with vaccinia GTase (residues
226–530) using DALI identified four capping enzyme GTases.
In order of similarity, these GTases are Chlorella virus GTase
(Z = 14.7; DALI) (Ha˚kansson et al., 1997), the GTase domain of
human capping enzyme (Z = 14.1; DALI) (Chu et al., 2011),
Candida albicans Cgt1 (Z = 11.5; DALI) (Fabrega et al., 2003),
and Saccharomyces cerevisiae Ceg1 (Z = 10.3; DALI) (Gu et al.,
2010). The vaccinia NTase fold consists of: (1) a central six-
stranded antiparallel b sheet (b13, b12, b11, b14, b15, b16), (2)
a four-stranded mixed b sheet (b9, b18, b17, b10), and (3) three
a helices (aF, aG, aH) (Figures 1D, 3A, and 3C). A structure-
based amino acid sequence alignment of the viral and human
GTases is shown in Figure S2. We will focus our discussion on
a comparison of the vaccinia and Chlorella virus GTases.
The vaccinia and Chlorella NTase domains differ most at
their N termini. Chlorella virus GTase has an additional module
composed of a two-stranded b sheet (b1-b2) and an a helix
(aA) at its N terminus that packs against the central b sheet (Fig-
ure 3C). In the vaccinia NTase domain, this helix is replaced by a
long loop that runs across the central b sheet and by the b9
strand, which is absent in the Chlorella virus enzyme.
The C-terminal OBmodule comprises a five-stranded antipar-
allel b sheet (b21, b20, b19, b25, and b26) with an inserted three-Structure 22,stranded antiparallel b sheet (b22, b23, b24) located beneath the
five-stranded b sheet (Figures 1D and 3A; Figure S3). The
inserted b sheet is a unique feature of the vaccinia GTase.
Toward the C terminus, there are two a helices (aI and aJ) flank-
ing the three- and five-stranded b sheets, respectively (Fig-
ure 1D). The OB fold domain of Chlorella virus GTase lacks helix
aI and has instead a C-terminal helix (aG) that folds back on the
NTase domain (Figure 3C). In vaccinia GTase, the equivalent
region interacts weakly with aH of the NTase domain (Figure 3A)
and leads into a long, disordered loop (530–544) connecting the
GTase with the MTase. This loop is protease-sensitive in the
native vaccinia virus capping enzyme (De la Pen˜a et al., 2007;
Shuman, 1989).
The NTase and the OB fold domains of the GTase form a deep
substrate-binding cleft. Chlorella virus GTase was crystallized in
two different conformations: an unreactive open conformation
with bound GTP and a catalytically active closed conformation
with bound GTP that could be converted in situ into the covalent
enzyme GMP adduct upon addition of manganese (Figure 3C)
(Ha˚kansson et al., 1997). Even in the absence of nucleotide,
the vaccinia GTase resembles the closed conformation of the
GTP-bound Chlorella virus GTase (Figure 3E), whereas for
human GTase (with sulfate in the active site), a range of confor-
mations from closed to half-open was observed (Chu et al.,
2011). In vaccinia GTase, the residue 467EVG468 at the tip of
the surface loop between strands b23 and b24 of the OBmodule
interacts with two surface loops of the NTase module, thereby
reinforcing the closed conformation of the GTase. Specifically,
the Glu467 main chain carbonyl accepts a hydrogen bond
from the Lys306 main chain amide, the Val468 carbonyl makes
van der Waals contacts with the Trp310-Cz2,CH2 indole atoms,
and Val468-Cg1 makes van der Waals contacts to His281-
Cd,Nε. The tip of this vaccinia OB fold loop is physically at the
same place as the turn of the extra N-terminal b-hairpin of the
Chlorella virus NTase domain.
The Guanylyltransferase Active Site
Cocrystals of the vaccinia virus capping enzyme with GTP
revealed density for the nucleotide in one of the two D1,D12
complexes in the asymmetric unit (Figure S5C). GTP binds
between the six-stranded and four-stranded b sheets of the
NTase module and induces no large-scale changes in the
enzyme, affecting only the conformations of a few side chains
in direct contact with the ligand. The defining features of the
vaccinia GTase active site are six conserved motifs that interact
with the guanine base (motifs IIIa and IV), the ribose hydroxyls
(motifs I and III), and the triphosphate moiety (motifs I, V, and
VI) of GTP (Shuman and Lima, 2004; Wang et al., 1997). Vaccinia
GTase motif I (260KTDGIP265) is located in the loop between b10
and b11 and contains Lys260, the active site lysine nucleophile
to which GMP becomes covalently attached (Niles and Christen,
1993).
The guanosine nucleoside adopts a syn conformation in the
vaccinia GTase. The base stacks between Ile315 (b15, motif
IIIa) and Ile378 (b17, motif IV), which correspond to Phe146
and Ile216 in Chlorella virus GTase. Guanine specificity is
conferred by hydrogen bonding between amino acid side chains
and the polar atoms of the nucleobase (Lys350 to O6 and N7,
Thr239 and Asp390 to N2). The triphosphate conformation in452–465, March 4, 2014 ª2014 Elsevier Ltd All rights reserved 457
Figure 3. The Guanylyltransferase Domain
(A) Ribbon representation of the vaccinia virus GTase in green with bound GTP and secondary structural elements labeled. Residues of the defining structural
motifs I, III, IIIa, IV, and V of the covalent nucleotidyltransferase family are highlighted and labeled in red, purple, blue, black, and brown, respectively. The same
color coding and labeling are used in parts (B), (C), and (D).
(B) Stereoscopic view of the active site of the vaccinia GTase showing bound GTP and key interacting residues with hydrogen bonds indicated by dotted
black lines.
(C) Ribbon representation of the Chlorella virus GTase with bound GTP in the closed conformation (PDB ID 1CKN chain B; light gray). The structural similarity of
vaccinia GTase as given by DALI to that of Chlorella virus is an rmsd of 3.2 A˚ over 216 aligned Ca positions, 17% sequence identity, and Z score 14.7.
(D) Active site of the Chlorella virus GTase in the closed conformation with bound GTP.
(E) Superposition of vaccinia (green) and the closed form ofChlorella virus (gray) GTases (gray), both with bound GTP. The angles between the NTase and OB fold
domains are indicated.
(F) Superposition of vaccinia GTase with bound GTP (green) and the open form of the Chlorella virus GTase with bound GpppG (gray). The angles between the
NTase and OB fold domains are indicated.
See also Figure S2.
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Vaccinia Virus Capping Enzyme Structurethe vaccinia complex differs from that in the closed form of the
Chlorella virus GTP complex and is not optimal for catalysis. In
the active Chlorella GTase, the Lys82-Nz nucleophile is 3.2 A˚
from the a phosphorus and is apical to the bridging a-b O3A
oxygen of the PPi leaving group. In the vaccinia GTase, Lys260
contacts the GTP a and b phosphate oxygens, but the a phos-
phate is not oriented properly for a nucleophilic attack by
Lys260 to form the enzyme-GMP adduct. Lys260-Nz is too
distant (3.8 A˚) from the a phosphorus and makes an acute angle
with respect to the PPi leaving group. We envision that this unfa-
vorable geometry is rectified when the essential Mg2+ ion is
bound in the active site. This ion is likely bound by the essential
motif IV acidic residue (Glu375 in vaccinia virus and Asp213 in
Chlorella virus GTases) that is conserved in all ATP-dependent
DNA and RNA ligases, nicotinamide adenine dinucleotide-
dependent DNA ligases, and GTP-dependent mRNA capping
enzymes (Cong and Shuman, 1995; Sawaya and Shuman,
2003; Wang et al., 1997). The metal is postulated to promote
catalysis by (1) coordinating the a phosphate and stabilizing
the negative charge developed on a phosphorane transition
state (Ha˚kansson et al., 1997; Nandakumar et al., 2006) and (2)
coordinating the Lys-Nz and favoring its deprotonation for nucle-
ophilic attack on the a phosphorus.
The GTP triphosphate moiety in the vaccinia GTase is coordi-
nated by basic residues in motif V (390DFKIKKENTID400) and
motif VI (493RIDK496). Motif V comprises strands b18 and b19
and their connecting loop, which joins the NTase module to
the OB module. Motif V Lys392, which is essential for RNA
capping activity (Cong and Shuman, 1995), makes a bifurcated
contact via Nz with the a-b bridging O3A and the b-phosphate
O2B. Lys394 points toward the b-phosphate, but is not within
hydrogen bonding distance. We suspect that the vaccinia motif
V lysine contacts with the phosphates may be reorganized in the
context of a Michaelis complex with Mg2+.
Motif VI (RxDK) in the OB module is essential for the activity of
cellular GTases (Sawaya and Shuman, 2003; Wang et al., 1997).
Motif VI of Chlorella virus GTase is located in a loop
(295RSDKNQAN302) connecting a b strand and an a helix of the
OB fold domain and is similarly situated in the S. cerevisiae,
C. albicans, andhumanGTases. In the catalytically poised closed
conformation of Chlorella virus GTase, Arg295 coordinates the
GTP b phosphate, whereas Lys298 and Asn302 engage the g
phosphate, thereby orienting the PPi leaving group apical to the
lysine nucleophile. In the vaccinia GTase, however, motif VI re-
sides entirely within helix aI (493RIDKTMKYN502). Despite the
distinctive secondary structureofmotif VI in thepoxvirus enzyme,
the Arg493 and Lys496 side chains engage theGTP g phosphate
oxygens, signifying a functional correspondence tomotif VI of the
cellular and Chlorella virus GTases. Lys496 also makes a salt
bridge to the putative metal-binding Asp400 carboxylate.
Vaccinia residue Asn502 occupies a position similar to that of
Asn302 in Chlorella virus GTase, but it is 5 A˚ away from the
GTP g phosphate, again suggestive that the vaccinia virus active
site configuration is not that of a Michaelis complex.
In sum, the structure of the GTase teaches us that the poxvirus
capping enzyme shares features of NTP recognition and catal-
ysis with other viral and cellular capping enzymes, as well as
with polynucleotide ligases, and highlights multiple distinctive
components of the poxvirus active site.Structure 22,The Interface between TPase and GTase
The TPase (Cet1) and GTase (Ceg1) components of the
S. cerevisiae capping apparatus are encoded as separate poly-
peptides that associate in vivo and in vitro to form a stable
Cet1,Ceg1 complex. The Cet1,Ceg1 crystal structure revealed
a heterotetramer composed of one Cet1 homodimer and two
molecules of Ceg1 (Gu et al., 2010). The main Cet1,Ceg1 inter-
action surface (1,900 A˚2) is between the OB fold domain of Ceg1
and the extremity of the N-terminal extension of the distal Cet1
after the latter has crossed over the proximal subunit of the
Cet1 homodimer. There is minimal interaction of the NTase
module of Ceg1 with Cet1, thereby allowing flexibility between
the OB and NTase domains.
The vaccinia TPase-GTase interface differs significantly from
that of Cet1 and Ceg1, although both bury comparable surface
accessible areas (2,155 A˚2 in the vaccinia interface versus
2,400 A˚2 for the Cet1-Ceg1 interface). The main difference is
that the vaccinia TPase makes substantial interactions with the
NTase (807 A˚2) and OB (1,348 A˚2) modules of the GTase, holding
them in a closed conformation (Figure 4A). In comparison, Ceg1
GTase is in a wide-open conformation (Gu et al., 2010). The
vaccinia TPase contacts the GTase mainly via the helices
packed against the TPase b barrel and the loops connecting
these helices to the tunnel. This structure results in a more rigid
connection between the two enzymes, in contrast to the flexible
connection between Cet1 and Ceg1. The relative orientation of
the TPase tunnel to the GTase differs markedly. In the vaccinia
enzyme, the tunnel entrance points directly toward the GTase
active site (Figure 5), whereas in the Cet1-Ceg1 structure, the
tunnel is rotated almost 45 around the axis, perpendicular to
the longitudinal tunnel, with the entrance pointing toward the
OB fold domain of Ceg1.
The interface of the vaccinia TPase and GTase comprises
three separate subinterfaces between (1) the TPase N-terminal
peptide and residues of the GTase b strand b11 of the central
b sheet and the long N-terminal loop located on top of the central
b sheet, (2) the TPase helix aB and GTase residues in helix aI and
b24 of the OB fold domain, and (3) the TPase residues in aD and
the loop connecting aD with b8 and GTase OB residues from
b21, b24, b25, their connecting loops, and helix aI. These inter-
faces are illustrated in Figure 4 and described in more detail in
the Supplemental Information.
Mutational Analysis of the TPase-GTase Interface
To address the importance of the interdomain contacts for
capping enzyme function, we introduced interfacial mutations
T10A, L47A-L50A-T51A, N181A, and R186A into the TPase
domain and K478A into the GTase domain of D1-(1–545), then
we assayed the affinity-purified wild-type and mutant recombi-
nant proteins (Figure S3A) for TPase and GTase activities. We
purified and tested in parallel a TPase-defective mutant E192A
that eliminates one of the metal-binding side chains in the TPase
active site tunnel. Velocity sedimentation analysis of the wild-
type D1-(1–545) protein verified that it sedimented as a discrete
monomeric component and that the GTase and TPase activity
profiles coincided with that of the D1-(1–545) polypeptide (Fig-
ures S3B and S3C). The relative activities of the D1-(1–545)-Ala
mutants vis-a`-vis the wild-type enzyme are shown in Figure 4D.
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Figure 4. The TPase-GTase Interface
(A) Overall ribbon representation of the vaccinia
TPase-GTase interface with the same coloring
scheme as in Figure 1C and secondary structural
elements involved in the TPase-GTase interface
labeled.
(B and C) Closeup stereoscopic views of the
corresponding areas marked in (A). For clarity, the
view in (B) is shown rotated 180 around the y axis,
allowing a view from the rear of the interface. Side
chains involved in interface formation are shown
as stick models, and hydrophobic interactions and
hydrogen bonds are presented as dotted lines in
magenta and black, respectively.
(D) Effects of alanine mutations at the TPase-
GTase interface on TPase and GTase activity.
Guanylyltransferase reaction mixtures (20 ml)
containing 50 mM Tris-HCl (pH 8.0), 5 mM dithio-
threitol (DTT), 5 mM MgCl2, 5 mM [a
32P]GTP, and
200-ng wild-type or mutant His10Smt3-D1-(1–545)
were incubated for 5 min at 37C. The reactions
were quenched with SDS, and the products were
analyzed by SDS-PAGE. The covalent enzyme-
[32P]GMP complex was visualized by autoradiog-
raphy of the dried gel and quantified by scanning
the gel with a phosphorimager. Triphosphatase
reaction mixtures (10 ml) containing 50 mM
Tris-HCl (pH 8.0), 2 mM DTT, 10 mM MgCl2,
1 mM [a32P]ATP, and 150 ng of wild-type or
mutant His10Smt3-D1-(1–545) were incubated for
30 minutes at 37C. The reactions were quenched
with 20 mM EDTA. An aliquot (6 ml) of the reaction
mixture was spotted onto a polyethyleneimine-
cellulose thin-layer chromatography (TLC) plate,
which was developed in 0.45 M (NH4)2SO4. The
release of [a32P]ADP was quantified by scanning
the TLC plate with a phosphorimager. The GTase
and TPase activities of the mutants were normal-
ized to the wild-type activity (defined as 100%).
See also Figure S3.
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Vaccinia Virus Capping Enzyme Structureimportant for capping enzyme function is that its replacement by
alanine must elicit at least a fourfold decrement in activity. There
was a clear hierarchy of mutational effects, the most instructive
of which were the lesions that resulted in a complete separation
of function. For example, the E192A enzyme with a TPase active
site mutation was fully active as a GTase but was crippled as a
triphosphatase (4% of wild-type activity) (Figure 4D). Two of
the interfacial mutations, L47A-L50A-T51A in the TPase domain
and K478A in the GTase domain, reduced GTase activity to less
than 1% of the wild-type level while sparing the TPase (42%–
43% of wild-type activity). Lys478 is at the center of a rich
network of cross-domain contacts between the aD helix, and
flanking loop of the TPase domain and the OB fold domain of
the GTase domain, especially the aI helix, which includes motif
VI side chains needed for GTase activity (Figure 4C). We surmise
that the K478A mutation destabilizes the active conformation of
the GTase. Note that other mutations in this portion of the inter-
face (N181A and R186A) did not exert a significant or selective
impact on GTase versus TPase activity (Figure 4D).
The L47A-L50A-T51A triple-mutation, which eliminates all of
the atomic contacts between the TPase aB helix and the OB
fold domain of the GTase (including the direct contacts of
Leu47 to the aI helix), also abolished GTase activity while preser-460 Structure 22, 452–465, March 4, 2014 ª2014 Elsevier Ltd All righving substantial TPase function (Figure 4D). These results high-
light the key role of the TPase interface with the OB fold domain
as a determinant of GTase activity. TPase interactions with the
NTase domain are also relevant insofar as the TPase T10A
mutation, which severs the contacts to the 224PEVV227 peptide
at the proximal margin of the NTase domain, results in a fivefold
decrement in GTase activity with no effect on the TPase
(Figure 4D).
These findings explain the long-standing conundrum in
analysis of the domain organization of vaccinia virus capping
enzyme, whereby efforts to define an autonomous GTase
domain by N-terminal deletion of the TPase were unsuccessful.
The Interface between the GTase and MTase Domains
A comparison with the previously described MTase,D12 struc-
ture (De la Pen˜a et al., 2007) reveals no significant structural
differences of the subcomplex in the full-length capping enzyme.
The vaccinia MTase is connected to the GTase via a
flexible linker (residues 529–543) that is disordered in all crystal
structures. This is followed by a region containing several resi-
dues required for the coordination of the methyl donor AdoMet
and for catalysis (De la Pen˜a et al., 2007; Zheng and Shuman,
2008a). In the full-length capping enzyme, this peptide ists reserved
Figure 5. MTase Interfaces with GTase
and D12
(A) Left: overall ribbon representation of the
vaccinia GTase-MTase interface. The color
scheme is the same as in Figure 1C. Secondary
structural elements contributing to the interface
are labeled. Right: stereoscopic view of the
marked area in left diagram. Side chains involved
in the interface and AdoHcy are shown as stick
models, and hydrophobic interactions and
hydrogen bonds are presented as dotted lines in
magenta and black, respectively.
(B) The MTase-D12 interface described the same
as in part (A).
See also Figure S4.
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Vaccinia Virus Capping Enzyme Structurewell-defined in the P21 crystal form 1, but residues 553–561 are
disordered in the P1 crystal form.
The crystal structure of full-length D1,D12 allows visualization
of an interface between an RNA (guanine-N7)-methyltransferase
and a GTase. This interface buries a surface area of around
917 A˚2 (432 A˚2 with NTase and 485 A˚2 with OB fold domain),
which is significantly less than the TPase-GTase interface. The
secondary structure elements of the MTase contributing to the
interface include the N-terminal peptide; helix aO; the b strands
b33; b34; b35 (inserted between b31 and aQ); and their connect-
ing loops. Their GTase components at the interface are b9, aF,
b17, and b18 from the NTase module and b20, b21 and aJ
from the OB module. This interface is illustrated in Figure 5A
and described in more detail in the Supplemental Information.
The Interface between the MTase Catalytic Domain
and D12
We previously described the interface between the vaccinia
MTase with the stimulatory D12 subunit and proposed a mecha-
nism for the allosteric effect ofD12on theMTase activitywhereby
the D12 helix aB0 packs against the C-terminal part of the MTase
helix aKmainly via hydrophobic interactions. This interaction sta-
bilizes this helix, which contains Asn570 and Lys573, two
conserved residues coordinating the methyl acceptor GTP and
the methyl donor AdoMet, respectively (De la Pen˜a et al.,
2007). To further investigate this interface, we introduced alanine
mutations for MTase residues Tyr571, Leu575, Leu576, Met579,
Phe585, Leu586, Asp587, Asp784, Asn785, Arg794, Phe798,
Met805, and Glu806 at the interface with the D12 subunit (Figure
5B). The His-tagged wild-type and mutant MTase catalytic do-Structure 22, 452–465, March 4, 2014mains D1-(540–844) were coexpressed
in Escherichia coli with untagged D12.
SDS-PAGE analysis of the affinity-
purified proteins revealed that D12 cop-
urified with D1-(540–844) in every case
(Figure S4A), signifying that none of the
interfacial mutations affected the hetero-
dimerization of the MTase catalytic
domain with D12 during protein produc-
tion in vivo in bacteria. The recombinant
proteinswere assayed formethyltransfer-
ase activity by label transfer from
[3H-CH3]AdoMet to GpppA cap dinucleo-tide. None of the alanine changes elicited a significant decrement
in MTase activity (Figure S4B). In addition, we tested the effects
of the alanine mutations on cap methylation activity in vivo in
yeast, taking advantage of the fact that coexpression of the
vaccinia D1 MTase catalytic domain and the D12 stimulatory
subunit in S. cerevisiae complements the lethality of a yeast
abd1D mutant that lacks the endogenous yeast cap guanine-
N7 methyltransferase enzyme Abd1 (Saha et al., 2003).
Coexpression of both vaccinia subunits is required for abd1D
complementation, and the genetic readout is sensitive to D1
mutations that affect methyltransferase catalytic activity (Saha
et al., 2003; Zheng and Shuman, 2008a, 2008b) and to certain
D12 mutations (Saha et al., 2003; Schwer and Shuman, 2006).
In the present study, we found that all of the interfacial alanine
mutants in the D1MTase were active in abd1D complementation
(Figure S4B). We conclude that none of the residues probed by
alanine scanning at the MTase-,D12 interface is critical per se
for biochemical or biological activity.
DISCUSSION
The vaccinia virus mRNA capping enzyme combines all
three enzymatic activities for cap 0 synthesis within one polypep-
tide chain. Our current and previous (De la Pen˜a et al., 2007)
structural studies reveal that the folds of the single components
are similar to capping enzyme components already structurally
characterized. TheTPase belongs to theTTM family that includes
yeast and mimivirus RNA triphosphatases, the GTase is a
member of the covalent nucleotidyltransferase superfamily that
comprises capping enzymes and polynucleotide ligases, andª2014 Elsevier Ltd All rights reserved 461
Figure 6. mRNA Cap Synthesis Pathway
between Active Sites
Two orthogonal views of the complete trifunctional
enzyme, in ribbon and surface representations,
showing the spatial relationship between the three
active sites. The color scheme is the same as in
Figure 1C, and ligands GTP and AdoHcy are
shown as space-filling models. Dotted black ar-
rows and brackets indicate ligands that are
obscured in a particular view. Possible paths of the
mRNA 50 end to enter successively the TPAse,
GTase, and MTase are shown in red.
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Vaccinia Virus Capping Enzyme Structurethe MTase belongs to the class I family of AdoMet-dependent
MTases.
The unification of the vaccinia RNA triphosphatase with the
TTM family resolves a longstanding conundrum about the struc-
ture and origins of this enzyme. Early studies of the vaccinia
TPase revealed what would emerge as the signature bio-
chemical feature of the TTM-type RNA triphosphatases: the
ability to hydrolyze NTP to nucleoside diphosphate and inor-
ganic phosphate in the presence of Mn2+ or Co2+ (Shuman
et al., 1980). The yeast Cet1 structure unveiled a then-novel
tunnel tertiary structure (Lima et al., 1999) that has since been
recognized as the founder of a TTM superfamily that extends
well beyond capping enzyme TPases (Gong et al., 2006; Jain
and Shuman, 2008). Amino acid sequence comparisons and
mutational analyses of metal-dependent RNA triphosphatases
of fungi, microsporidia, protozoans, and Chlorella virus high-
lighted conservation of the b strands and essential amino acids
that compose the active site tunnel of yeast Cet1, implying a
common structure and evolutionary origin for these enzymes
(Shuman, 2002). This view was later fortified by the structure of
mimivirus TPase (Benarroch et al., 2008). However, the vaccinia
TPase had no recognizable primary structural similarity to the
fungal, protozoan, Chlorella virus, or mimivirus TPases, except
for the metal-binding motifs A and C. Whereas mutational
studies had identified constituents of the vaccinia TPase active
site, and though researchers predicted that some of these would
reside in b strands (e.g., 74VKIRTKI80 and 158IDFKLKY164), it was
inferred that the poxvirus TPases lack a topologically closed
tunnel architecture (Gong and Shuman, 2003). The present
structure vitiates that notion while showing that several of the
active site constituents of vaccinia TPase are indeed deployed
in a distinctive manner (i.e., in different b strands of the tunnel)
vis-a`-vis other TTM RNA triphosphatases.462 Structure 22, 452–465, March 4, 2014 ª2014 Elsevier Ltd All rights reservedThe structure of the full-length D1 pro-
tein adds information on the disposition
of the catalytic domains and their inter-
faces. The N-terminal decapeptide and
tunnel-surrounding helices of the TPase
domain interact with the NTase and OB
modules, respectively, of the GTase
domain. In this way, the vaccinia TPase
clamps the GTase in a conformation
similar to the closed conformation of
Chlorella virus capping enzyme, but
unlike the Cet1-Ceg1 complex or the iso-lated C. albicans and human GTases, in which the relative orien-
tation of the NTase and OB modules is flexible. It is therefore
unlikely that the vaccinia GTase undergoes the same degree of
inter-NTase-OB fold domain movement as that observed in
Chlorella virus and cellular GTases, as well as in ATP-dependent
DNA ligases. Consistent with this idea is our observation that
residues in the vaccinia TPase-GTase interface have profound
effects on GTase activity. In particular, the mutations L47A-
L50A-T51A, K478A, and T10A resulted in separations of function
whereby the mutant enzymes were inactive or partially defective
in GTase activity, but were spared with respect to TPase
function.
The salient characteristic of the open conformations of GTases
and DNA ligases is that motif VI is remote from the NTP b and g
phosphates. In the vaccinia GTase, motif VI engages the GTP
phosphates, but the geometry of the triphosphate moiety
observed in our structure is inimical to catalysis. We presume
that the triphosphate conformation and certain atomic contacts
of the active site functional groups will be remodeled in the
Michaelis complex of the GTase reaction, especially when the
catalytic Mg2+ engages the GTP a phosphate and the noncata-
lytic Mg2+ bridges the b and g phosphates.
The orientation of the TPase tunnel relative to the GTase active
site in the vaccinia virus capping enzyme is well-suited for
sequential action. Although bound NTP substrate has not been
observed in any available RNA triphosphatase structure, it is
hypothesized on the basis of positions of a bound divalent cation
and a sulfate (mimicking the g phosphate) in the yeast Cet1
TPase structure that the pppRNA 50 end substrate enters the tun-
nel from the direction depicted in Figure 6. In the vaccinia sys-
tem, the TPase tunnel is positioned so that its entrance points
directly toward theGTase active site. On the basis of the vaccinia
enzyme structure, we can imagine that the mRNA triphosphate
Structure
Vaccinia Virus Capping Enzyme Structure50 end enters the deep groove formed by the TPase, OB fold, and
MTase, giving it access to the TPase, and then, after conversion
to a 50 diphosphate RNA, to the GTase active site (Figure 6, left).
By contrast, the transition from the GTase to the MTase active
site is less clear insofar as the MTase site is on the opposite
side of the D1,D12 heterodimer (Figure 6, right). It is possible
that the GpppRNA continues to track around the protein surface
in the same direction in the groove between the NTase, MTase,
and D12 subunits (path A), taking advantage of the U-shaped
form of the complex, but this path is a long way around. Alterna-
tively, the GpppRNA could dissociate from the GTase and rebind
to the MTase active site (path B). In any case, it should be borne
in mind that the capping enzyme is directly associated with the
vaccinia RNA polymerase (Hagler and Shuman, 1992), which
means that the 50 end of the nascent mRNA will stay in proximity
to the capping enzyme even if dissociated from a particular
capping enzyme active site. Furthermore, mRNA elongation by
the polymerase could be a driving force to move the 50 end
from one active site to the next. Although our structures provide
insights into the architecture of the complete vaccinia virus
capping enzyme, we must await a next generation of structures
of the enzymes in complexes with pppRNA, ppRNA, and
GpppRNA ligands to illuminate how the mRNA 50 end proceeds
from one site to the next and whether significant conformational
changes not observed to date in any crystal form play a role in
these transitions.
The D1,D12 structure raises interesting questions about the
evolution of the mRNA capping apparatus. The poxvirus D1 sub-
unit comprises TPase, GTase, and MTase catalytic domains
arrayed in the same linear order in the D1 polypeptide as the
sequential capping reactions they perform. The structural simi-
larities of the poxvirus TPase, GTase, and MTase modules to
the separately encoded TPase, GTase, and MTase enzymes of
fungi and microsporidia (Fabrega et al., 2003, 2004; Lima et al.,
1999) argues that the poxvirus capping enzyme evolved by
gene fusion events. The fact that other large eukaryal DNA
viruses, such as African swine fever virus and mimivirus, also
encode D1-like TPase-GTase-MTase polypeptides (Benarroch
et al., 2008; Pena et al., 1993), as do virus-like cytoplasmic
plasmids of fungi (Tiggemann et al., 2001), suggests a common
ancestry for the DNA virus and virus-like trifunctional capping
enzymes (Shuman, 2002).
New clues to this ancestry can be found in the growing collec-
tion of giant DNA viruses that have been isolated from marine
protozoa and eukaryal phytoplankton in the wake of the discov-
ery of mimivirus. The giant DNA viruses that encode poxvirus-/
mimivirus-like TPase-GTase-MTase polypeptides are as follows
(with viral genome sizes and capping enzymepolypeptide acces-
sion numbers and sizes indicated in parentheses): Megavirus
chiliensis (1.26 Mb; NCBI Reference Sequence YP_004894563;
1164 aa), Acanthamoeba polyphaga moumouvirus (1.02 Mb;
NCBI Reference Sequence YP_007354410; 1162 aa), Cafeteria
roenbergensis virus (0.73 Mb; NCBI Reference Sequence
YP_003969844; 1015 aa), Phaeocystis globosa virus (0.46 Mb;
NCBI Reference Sequence YP_008052553; 1191 aa), Marseille-
virus (0.37 Mb; NCBI Reference Sequence YP_003407048;
819 aa), and Organic Lake phycodnavirus 2 (0.3 Mb;
EMBL:ADX06468; 942 aa). By contrast, the largest known
eukaryal DNA virus, Pandoravirus salinus (2.5 Mb genome)Structure 22,encodes three separate capping enzymes: a TTM-type TPase
(NCBI Reference Sequence YP_008436986; 333 aa), a GTase
(NCBI Reference Sequence YP_008437195; 482 aa), and a
MTase (NCBI Reference Sequence YP_008436891; 452 aa).
The D12 subunit is a distinctive feature of the poxvirus capping
enzyme. As noted previously, the D12 structure resembles a
degenerate cap 20-O-MTase domain insofar as it is structurally
similar to the cap 20-O-MTases of reovirus l and flavivirus RNA
polymerase but lacks the AdoMet binding site (De la Pen˜a
et al., 2007). We surmise that poxvirus D1,D12 descended
from a multifunctional viral enzyme that was capable of synthe-
sizing a cap 1 structure, m7GpppNm. Erosion of the erstwhile
MTase function of vaccinia D12 was presumably compensated
by the acquisition of a separately encoded cap 20-O-MTase
enzyme, VP39 (Schnierle et al., 1992). There is apparent selec-
tive pressure to maintain D12 as a subunit of the vaccinia virus
capping enzyme by virtue of: (1) its necessity for optimal MTase
activity of the D1 subunit and (2) its requirement for the transcrip-
tion termination factor activity of vaccinia virus capping enzyme
during synthesis of poxvirus early mRNAs by the viral RNA poly-
merase (Luo et al., 1995).
EXPERIMENTAL PROCEDURES
Full description of the methods is given in the Supplemental Experimental
Procedures.
Expression and Crystallization of Vaccinia Virus Capping Enzyme
D1, with an N-terminal tobacco etch virus (TEV) protease cleavable His10 tag,
was coexpressed with D12 in E. coli strain BL21Star(DE3)pLysS, and the com-
plex was purified by two steps of nickel-nitrilotriacetic acid affinity chromatog-
raphy (before and after His-tag cleavage by His-tagged TEV), followed by
heparin and then Superdex 200 columns (Pharmacia). A purified complex at
4 mg/ml was used with 5 mM AdoMet, 1 mM magnesium chloride, and
2 mM m7GpppG for crystal screening. After optimization, platelike crystals,
often in stacks, were grown from 0.1 M 2-(N-morpholino)ethanesulfonic
acid, pH 6.0, 1 M LiCl, and 10%PEG-6000 at 20C using the sitting drop vapor
diffusion technique. These crystals belong to space group P1 with two
molecules per asymmetric unit (form 2). Crystals with similar morphology
were grown from 0.1 M Tris-HCl, pH 7.5, 0.2 M LiCl, 0.2 M (NH4)2SO4, and
15% PEG-4000. These crystals belong to the space group P21 with two mol-
ecules per asymmetric unit (form 1). Form 1 crystals containing GTP were
grown in the presence of 100 mM GTP, 5 mM manganese chloride, and
5 mM AdoMet from 0.1 M citric acid, pH 6.5, 1.2 M LiCl, and 6% PEG-6000.
Data Collection, Phase Determination, and Structure Refinement
Diffraction data from cryoprotected crystals were collected at the European
Synchrotron Radiation Facility beamlines and processed with the XDS X-Ray
Detector Software package (http://xds.mpimf-heidelberg.mpg.de/) (Kabsch,
1993). The D1,D12 structure was solved by molecular replacement using the
MTase,D12 subcomplex (pdb 2VDW, 51% of the total) in combination with
cross-crystal averaging of four data sets and the two D1,D12 complexes in
each asymmetric unit: native data sets in P21 and P1, a selenomethionine-
labeled derivative and a nonisomorphous platinum derivative, with resolutions
of 2.9 A˚, 2.9 A˚, 3.5 A˚, and 3.2 A˚, respectively. TheRESOLVEbuild script (https://
solve.lanl.gov/), which performs automatic, iterative, density modification,
noncrystallographic symmetry (NCS) averaging, and model building, was
very useful for model construction (Terwilliger, 2003). Structures were refined
according to standard procedures using NCS restraints and TLS parameters.
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